Other Cancers

8 protocols meet the specified criteria.

  • A151804

    Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

  • A211901

    Reaching Rural Cancer Survivors Who Smoke Using Test-Based Cessation Interventions

  • EAY191

    Molecular Analysis for Combination Therapy Choice (ComboMATCH)

  • GRAIL-MA-002

    REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity (REACH/Galleri-Medicare study)

  • NKT5097-101

    A Phase 1, First-in-Human, Open-Label Study to Evaluate the Safety, Tolerability, PK, and Preliminary Anti-tumor Activity of the Novel Oral Selective CDK2/4 Dual Degrader NKT5097 in Adults with Advanced/Metastatic Solid Tumors

  • WVU011625

    The role of scheduled intravenous fluids in the supportive management of patients undergoing chemo-radiotherapy for head and neck cancers

  • WVU020924

    Phase I/II study of leflunomide in combination with decitabine for treatment of relapsed or refractory myelodysplastic syndromes

  • WVU03HSC24

    Evaluating the gut microbiome from diagnosis through surveillance in colorectal cancer patients in Appalachia